Latest Headlines

Latest Headlines

Bridgewest merges China-focused BioDuro with Formex in San Diego base

China-focused CRO BioDuro has merged with manufacturing company Formex in the U.S. as part of an apparent reorganization under owner Bridgewest Group with all three companies located in San Diego.

The color purple foils Dr. Reddy's Nexium generic in U.S.

A U.S. court has barred Dr Reddy's Laboratories from selling its generic of AstraZeneca's heartburn drug Nexium after AstraZeneca objected to the Indian drugmaker's use of the color purple for the pills, according to reports.

FDA widens review of Dr. Reddy's manufacturing ops

Dr Reddy's Laboratories has again come under the spotlight of the U.S. Food and Drug Administration which has ordered a third-party audit covering the entire manufacturing network of the company, according to a report by  Livemint.

India's Sun Pharmaceutical takes another Ranbaxy-related hit

Mumbai-based Sun Pharmaceutical Industries saw net profit slump nearly a third in its financial second quarter as costs related to its purchase of troubled Ranbaxy Laboratories continue to hound operations.

Ready-to-assemble GE drug plants hit the ground in China

In this day of instant gratification, instant feedback via social media and fast food and fast fashion, General Electric wants to add fast prefabricated drug manufacturing plants to the list.

Dr. Reddy's eyes biosimilars for emerging markets

India's Dr Reddy's Laboratories is looking to increase sales of biosimilars in emerging markets and plans to launch products in Russia as well as licensing deals in Southeast Asia, its chief operating officer told an earnings call, according to a Reuters report.

Novartis to close one Indian manufacturing plant as FDA warning bites

Swiss-based Novartis will close a manufacturing plant in India, CEO Joe Jimenez said on the Oct. 27 third quarter earnings call, noting that the company has moved on remediation plans following inspections, but still received a U.S. FDA warning letter.

NY-based Athenex has big China manufacturing plans with name change to boot

A manufacturing pact in China's Chongqing will see U.S.-based Athenex build two drug manufacturing plants at Banan that will receive local funding for land and construction, the company formerly known as Kinex said in a press release.

Vietnam's Vinamilk on the block--will Abbott bite?

A move in the past week by Vietnam to say it wants to sell major stakes in state-owned companies might be a dealmaking cue for Abbott Laboratories, which noted a sharp slowdown in nutrition sales in Vietnam in the second quarter.

Indian drug manufacturers face higher costs with bar-code requirement

Small and medium-sized Indian drugmakers are decrying a move by the government to impose new bar-code requirements and say the action shows the government is taking sides with big multinational players to elbow out smaller competition. The larger companies are saying the move is necessary to protect the country's reputation.